Mimicking of Estradiol Binding by Flame Retardants and Their Metabolites: A Crystallographic Analysis

Abstract

Background: Brominated flame retardants (BFRs), used in many types of consumer goods, are being studied because of concerns about possible health effects related to endocrine disruption, immunotoxicity, reproductive toxicity, and neurotoxicity. Tetrabromobisphenol A (TBBPA), the most widely used BFR, and human metabolites of certain congeners of polybrominated diphenyl ether (e.g., 3-OH-BDE-47) have been suggested to inhibit estrogen sulfotransferase, potentially affecting estrogen metabolism.Objectives: Our primary goal was to understand the structural mechanism for inhibition of the hormone-metabolizing enzyme estrogen sulfotransferase by certain BFRs. We also sought to understand various factors that facilitate the binding of flame retardants in the enzyme binding pocket.Methods: We used X-ray crystallography to obtain atomic detail of the binding modes of TBBPA and 3-OH-BDE-47 to estrogen sulfotransferase for comparison with binding of the endogenous substrate estradiol.Results: The crystal structures reveal how BFRs mimic estradiol binding as well as the various interactions between the compounds and protein residues that facilitate its binding. In addition, the structures provide insights into the ability of the sulfotransferase substrate binding pocket to accommodate a range of halogenated compounds that satisfy minimal structural criteria.Conclusions: Our results show how BFRs or their metabolites can bind to and inhibit a key hormone-metabolizing enzyme, potentially causing endocrine disruption.Citation: Gosavi RA, Knudsen GA, Birnbaum LS, Pedersen LC. 2013. Mimicking of estradiol binding by flame retardants and their metabolites: a crystallographic analysis. Environ Health Perspect 121:1194–1199; http://dx.doi.org/10.1289/ehp.1306902

Measured and predicted affinities of binding and relative potencies to activate the AhR of PAHs and their alkylated analogues

“…Binding distance has been used as a tool for docking scoring and for evaluation of contact between ligand and LBD (Baker and Chandsawangbhuwana, 2012;Gosavi et al, 2013;Park et al, 2011). Alteration of binding distance between ligand and each binding domain accounts for changes in estrogenic potency of 4-methyl-2,4-bis(4-hydrozyphenyl)pent-1-ene (MBP), a bisphenol A (BPA) metabolite, compared to that of its unsubstituted compound (Baker and Chandsawangbhuwana, 2012).…”

Exposure of general population to PBDEs: A Progressive Total Diet Study in South Korea

“…The same group also reported hydroxylated BDEs to have mutagenic potential and exhibit dioxin-like toxicity as AhR-agonists (Su et al, 2012a(Su et al, , 2014. In addition, OH-BDEs were also observed to inhibit the enzyme SULT1E1 in humans and potentially affect estrogen metabolism (Gosavi et al, 2013).…”

Endocrine disrupting chemicals and the battle to ban them

“…Brominated flame retardants, PBDEs, are an example of EDCs that are both persistent and bio accumulative; they can mimic the female hormone oestrogen and thus interfere with the action of the body's natural hormones. (Gosavi RA, et al, 2013).…”